Genpact Form 144: 2,326 Restricted Shares Acquired 12/31/2019 to Be Sold via Morgan Stanley

Rhea-AI Filing Summary

Genpact Limited submitted a Form 144 notice for the proposed sale of 2,326 common shares, with an aggregate market value of $100,413.42. The shares represent a small fraction of the issuer's outstanding common stock (174,270,076 shares outstanding) and were acquired as restricted stock on 12/31/2019. The broker listed is Morgan Stanley Smith Barney LLC and the securities are designated for sale on the NYSE with an approximate sale date of 08/12/2025. The form indicates no securities sold in the past three months and includes the signer’s representation that they are not aware of undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Small, routine Form 144 notice; transaction size is immaterial to Genpact’s market capitalization.

The filing reports a proposed sale of 2,326 restricted shares valued at about $100k against 174.27 million shares outstanding, representing a de minimis percentage of equity and unlikely to move market prices or alter fundamentals. The use of a major broker and the absence of any sales in the prior three months suggest this is a controlled, compliance-driven disclosure rather than a signal of material change. Impact is neutral for investors.

Corporate Governance Expert

TL;DR: Disclosure appears procedurally correct and non-material; signature attests to lack of undisclosed adverse information.

The notice documents acquisition as restricted stock and lists broker and exchange details, meeting Rule 144 disclosure norms. The filer’s representation regarding material information is standard and important for regulatory compliance. Given the small lot size and clear acquisition history, this filing raises no governance red flags or material control issues for shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2326	100413.42	174270076	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2019	Restricted Stock	Issuer			2326	12/31/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Genpact (G) Form 144 notice disclose?

It discloses a proposed sale of 2,326 common shares with an aggregate market value of $100,413.42, to be sold on the NYSE via Morgan Stanley Smith Barney LLC.

When were the shares acquired that are proposed for sale in Genpact (G)?

The shares were acquired on 12/31/2019 and are described as restricted stock.

Are any Genpact (G) securities reported sold in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker and what is the approximate sale date in the Form 144 for Genpact (G)?

Broker: Morgan Stanley Smith Barney LLC. Approximate sale date: 08/12/2025.

How large is the proposed sale relative to Genpact’s outstanding shares?

The proposed 2,326 shares are a very small portion of the 174,270,076 shares outstanding reported in the form.